Publications

5808 Results

A phase II study of erlotinib (OSI-774) in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317 [PMC2793000; PMID19884559]

Authors
MS Gordon;MA Hussey;RB Nagle;PN Lara;PC Mack;JP Dutcher;WE Samlowski;JI Clark;DI Quinn;CX Pan;ED Crawford
Journal / Conference
Journal of Clinical Oncology 27(34):5788-5793
Year
2009
Research Committee(s)
Genitourinary
Study Number(s)
S0317

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer, a phase III trial of the Gynecologic Cancer InterGroup (GCIG) [PMC2668552;PMID19224846]

Authors
M Bookman;M F Brady;WP McGuire;P Harper;D Alberts;M Friedlander;N Colombo;J Fowler;PA Argenta;K DeGeest;D Mutch;RA Burger;AM Swart;EL Trimble;C Accario-Winslow;L Roth
Journal / Conference
Journal of Clinical Oncology 27(9):1419-1425
Year
2009
Research Committee(s)
Gynecologic
Study Number(s)
G0182

Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for breast cancer: results from an ancillary study to Southwest Oncology Group Trial S8897 (INT-0102). [PMC2799053;PMID19752340]

Authors
CB Ambrosone;W Barlow;W Reynolds;RB Livingston;IT Yeh;JY Choi;W Davis;JM Rae;L Tang;L Hutchins;PM Ravdin;S Martino;CK Osborne;M Abeloff;AP Lyss;DF Hayes;KS Albain
Journal / Conference
Journal of Clinical Oncology 27(30):4973-4979
Year
2009
Research Committee(s)
Breast
Study Number(s)
SWOG-8897

A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-hodgkins lymphoma: Southwest Oncology Group study S0108 [PMID19373598; PMC3532923]

Authors
A Stopeck;J Unger;L Rimsza;W Bellamy;M Iannone;D Persky;M LeBlanc;R Fisher;T Miller
Journal / Conference
Leukemia and Lymphoma 50(5):728-735
Year
2009
Research Committee(s)
Lymphoma
Study Number(s)
S0108

Natural history of central nervous system (CNS) relapse in patients with aggressive non-hodgkin's lymphoma: a 20 year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group [PMID19047289]

Authors
SH Bernstein;JM Unger;M LeBlanc;JW Friedberg;TP Miller;RI Fisher
Journal / Conference
Journal of Clinical Oncology 27(1):114-119
Year
2009
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8516 (INT-0067)

Prostate-specific antigen progression (PSA-P) predicts overall survival (OS) in patients with metastatic prostate cancer: data from Southwest Oncology Group (SWOG) trials 9346 (INT 0162) and 9916 [PMC2684851; PMID19380444]

Authors
M Hussain;B Goldman;C Tangen;CS Higano;DP Petrylak;G Wilding;A Akdas;EJ Small;BJ Donnelly;L Collette;PA Burch;RS DiPaola;ED Crawford
Journal / Conference
Journal of Clinical Oncology 27(15):2450-2456
Year
2009
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346, S9916

A sequential treatment approach to myoinvasive urothelial cancer: a phase II Southwest Oncology Group Trial (S0219) [PMC2769926; PMID1937909]

Authors
RW de Vere White;PN Lara;B Goldman;CM Tangen;DC Smith;DP Wood;MHA Hussain;ED Crawford
Journal / Conference
Journal of Urology 181(6):2476-2480
Year
2009
Research Committee(s)
Genitourinary
Study Number(s)
S0219

A randomized phase III non-inferiority trial of irinotecan (CPT-11) versus oxaliplatin (OXAL)/5-fluorouracil (5-FU)/leucovorin (CF) in patients with advanced colorectal carcinoma previously treated with 5-FU, N9841 [PMC2698019; PMID19380443]

Authors
GP Kim;DJ Sargent;MR Mahoney;KM Rowland;PA Philip;E Mitchell;AP Mathews;TR Fitch;RM Goldberg;SR Alberts;HC Pitot
Journal / Conference
Journal of Clinical Oncology 27(17):2848-2854
Year
2009
Research Committee(s)
Gastrointestinal
Study Number(s)
N9841

Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the North Central Cancer Treatment Group Phase 3 trial (N9831) [PMC2690390; PMID19349549]

Authors
MY Halyard;TM Pisansky;AC Dueck;V Suman;L Pierce;L Solin;L Marks;N Davidson;S Martino;P Kaufman;L Kutteh;SR Dakhil;EA Perez
Journal / Conference
Journal of Clinical Oncology 27(16):2638-2644
Year
2009
Research Committee(s)
Breast
Study Number(s)
N9831

Quality of pathologic response and surgery correlate with survival for completely resected bladder cancer following neoadjuvant MVAC

Authors
G Sonpavde;B Goldman;VO Speights;SP Lerner;DP Wood;NJ Vogelzang;DL Trump;RB Natale;HB Grossman;ED Crawford
Journal / Conference
ASCO 2009 GU Cancers Symposium, abst. #249
Year
2009
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)